Finally, treatment with the MANS peptide impaired cell migration in vitro and the metastatic potential of invasive lung cancer cells in vivo, through coordination of increase of E-cadherin expression, suppression of MARCKS phosphorylation and AKT/SLUG signaling pathway. The gene discussed is AKT1; the disease is lung cancer.